179 related articles for article (PubMed ID: 15507875)
1. Neurokinin receptors: relevance to the emerging immune system.
Kang HS; Trzaska KA; Corcoran K; Chang VT; Rameshwar P
Arch Immunol Ther Exp (Warsz); 2004; 52(5):338-47. PubMed ID: 15507875
[TBL] [Abstract][Full Text] [Related]
2. Tachykinins and tachykinin receptors in bone.
Goto T; Tanaka T
Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
[TBL] [Abstract][Full Text] [Related]
3. Tac1 regulation by RNA-binding protein and miRNA in bone marrow stroma: Implication for hematopoietic activity.
Murthy RG; Greco SJ; Taborga M; Patel N; Rameshwar P
Brain Behav Immun; 2008 May; 22(4):442-50. PubMed ID: 18061399
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic modulation by the tachykinins.
Rameshwar P; Gascón P
Acta Haematol; 1997; 98(2):59-64. PubMed ID: 9286300
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter.
Bandari PS; Qian J; Oh HS; Potian JA; Yehia G; Harrison JS; Rameshwar P
J Neuroimmunol; 2003 May; 138(1-2):65-75. PubMed ID: 12742655
[TBL] [Abstract][Full Text] [Related]
6. Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells.
Greco SJ; Corcoran KE; Cho KJ; Rameshwar P
Front Biosci; 2004 May; 9():1782-93. PubMed ID: 14977586
[TBL] [Abstract][Full Text] [Related]
7. The anti-proliferative effect of neurokinin-A on hematopoietic progenitor cells is partly mediated by p53 activating the 5' flanking region of neurokinin-2 receptor.
Vishalakumar S; Patel H; Moharita AL; Harrison JS; Rameshwar P
Cell Signal; 2006 Apr; 18(4):422-32. PubMed ID: 16009534
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines.
Rameshwar P; Poddar A; Gascón P
Leuk Lymphoma; 1997 Dec; 28(1-2):1-10. PubMed ID: 9498698
[TBL] [Abstract][Full Text] [Related]
9. Substance P and the neurokinins: novel peptide neurotransmitters in psychopharmacology.
Stahl SM
J Clin Psychiatry; 1999 Feb; 60(2):77-8. PubMed ID: 10084632
[TBL] [Abstract][Full Text] [Related]
10. mRNA expression of tachykinins and tachykinin receptors in different human tissues.
Pinto FM; Almeida TA; Hernandez M; Devillier P; Advenier C; Candenas ML
Eur J Pharmacol; 2004 Jun; 494(2-3):233-9. PubMed ID: 15212980
[TBL] [Abstract][Full Text] [Related]
11. Tachykinins and hematopoiesis.
Liu K; Castillo MD; Murthy RG; Patel N; Rameshwar P
Clin Chim Acta; 2007 Oct; 385(1-2):28-34. PubMed ID: 17698052
[TBL] [Abstract][Full Text] [Related]
12. Tachykinins and hematopoietic stem cell functions: implications in clinical disorders and tissue regeneration.
Murthy RG; Reddy BY; Ruggiero JE; Rameshwar P
Front Biosci; 2007 May; 12():4779-87. PubMed ID: 17485413
[TBL] [Abstract][Full Text] [Related]
13. Effects of ischemia on tachykinin-containing nerves and neurokinin receptors in the rabbit bladder.
Azadzoi KM; Radisavljevic ZM; Siroky MB
Urology; 2008 May; 71(5):979-83. PubMed ID: 18314167
[TBL] [Abstract][Full Text] [Related]
14. Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: a novel method in neural-hematopoietic axis.
Ricardo M; Trzaska KA; Rameshwar P
J Neuroimmunol; 2008 Nov; 204(1-2):85-91. PubMed ID: 18760489
[TBL] [Abstract][Full Text] [Related]
15. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.
Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP
Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypoxia on the hematopoietic and immune modulator preprotachykinin-I.
Quinlan DP; Rameshwar P; Qian J; Maloof PB; Mohr AM; Hauser CJ; Livingston DH
Arch Surg; 1998 Dec; 133(12):1328-34. PubMed ID: 9865651
[TBL] [Abstract][Full Text] [Related]
17. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
18. Tachykinins in the lungs.
Chapman RW; Hey JA; McLeod R; Minnicozzi M; Rizzo C
Drug News Perspect; 1998 Oct; 11(8):480-9. PubMed ID: 15616676
[TBL] [Abstract][Full Text] [Related]
19. Role for NK(1) and NK(2) receptors in the motor activity in mouse colon.
Mulè F; Amato A; Serio R
Eur J Pharmacol; 2007 Sep; 570(1-3):196-202. PubMed ID: 17597603
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
